Cagri-Sema
Two metabolic peptides in one vial · From $92
Overview
A two-component vial pairing the long-acting amylin analogue with the acylated GLP-1 receptor agonist, 5 mg each. Amylin and GLP-1 act at separate receptor systems, and the pair is used in receptor-binding, cAMP-accumulation and rodent energy-balance work examining co-agonism of the two pathways. Purity is reported per component on the certificate.
- Purity
- ≥ 99%
- Form
- Lyophilized powder
- Components
- 2, 10 mg total
- Storage
- −20 °C, desiccated, dark
Also known as Cagrilintide / Semaglutide, CagriSema.
Research explained
The research interest
This blend combines two compounds involved in appetite-related signalling research.
What was studied
The selected papers describe cagrilintide and semaglutide individually.
Evidence context
The selected sources cover ingredients separately. Combination research and testing this exact mixture are separate assessments.
Selected-source check, not a complete clinical review. No human-use recommendation.
Components
Specifications
Composition
- Cagrilintide
- 5 mg
- Semaglutide
- 5 mg
- Total peptide
- 10 mg
Material
- Purity, RP-HPLC
- ≥ 99%
- Form
- Lyophilized powder
- Appearance
- White to off-white lyophilized powder
- Vial sizes
- 10 mg
Handling
- Solubility
- Soluble in water and aqueous buffers. Laboratory solvent compatibility only.
- Storage
- Lyophilized powder stored at -20 °C, desiccated and protected from light; long-term storage at -80 °C. Avoid repeated freeze-thaw cycles of stock solutions.
Literature and research use
Literature is cited on each component's own listing.
Citations describe published preclinical and in-vitro findings for this compound class and are not a representation about this material.
Research use only
All products listed on this site are supplied strictly as chemical reference materials for in-vitro laboratory research and are labelled For Research Use Only. They are not drugs, foods, cosmetics, or medical devices. They are not intended to diagnose, treat, cure, or prevent any condition, and are not for human or veterinary consumption or administration under any circumstances.
Research use policy ›